Cornea Department, Disha Eye Hospitals, Barrackpore, Kolkata, India.
Cornea. 2022 Apr 1;41(4):512-517. doi: 10.1097/ICO.0000000000002922.
The purpose of this study was to describe a novel bandage contact lens (BCL) interface technique for marking the Descemet membrane endothelial keratoplasty (DMEK) graft so that a single donor cornea can be used effectively for 2 recipients during acute shortage.
This was a retrospective comparative case series. In group A, 37 eyes underwent DMEK using a graft marked by the ‟BCL interface technique" that was compared with 49 conventional DMEK grafts marked through the stromal window (group B). In group A, a resized BCL with a central 3-mm hole with the concavity up was placed between the stroma and peeled-off DM. This BCL with DM was flipped for S-stamping on the DM side. Final trephination was performed on a second Teflon block. The remaining anterior lamellar tissues of group A were used on the same day for other keratoplasty procedures. Endothelial cell density (ECD) and endothelial cell loss between the 2 groups were compared after 3 and 6 months.
The ECD at 3 months in group A (n = 35) versus group B (n = 45) was 2228 ± 270/mm2 versus 2302 ± 254/mm2 (P = 0.48), and the ECD at 6 months (n = 23 and 22) was 2058 ± 324/mm2 versus 2118 ± 260/mm2 (P = 0.72). The corresponding endothelial cell loss was 23.3% ± 6.8% versus 20.3% ± 6.1% (P = 0.18) at 3 months and 29.1% ± 8.4% versus 26.7% ± 8.0% (P = 0.34) at 6 months. Among anterior tissues of group A, 17 (45.9%) were used for deep anterior lamellar keratoplasty, 18 (48.6%) were used for larger therapeutic and tectonic grafts, and 2 were used as keratoprosthesis carriers. Donor detachment rate (8.6% vs. 8.9%) was similar in both groups without primary graft failures.
The BCL interface technique is a simple and safe technique for stamping DMEK grafts. Anterior corneal tissues can be used for additional keratoplasties during donor shortage.
本研究旨在描述一种新型绷带接触镜(BCL)接口技术,用于标记Descemet 膜内皮角膜移植术(DMEK)移植物,以便在急性短缺期间,有效利用单个供体角膜为 2 名受者服务。
这是一项回顾性对照病例系列研究。在 A 组中,37 只眼采用通过“BCL 界面技术”标记的移植物进行 DMEK 手术,与 49 只通过基质窗(B 组)标记的常规 DMEK 移植物进行比较。在 A 组中,将一个带有中央 3mm 孔、凹面朝上的重新调整大小的 BCL 置于基质和剥离的 DM 之间。将带有 DM 的 BCL 翻转以在 DM 侧进行 S 标记。在第二个特氟隆块上进行最终环钻。A 组的剩余前板层组织在同一天用于其他角膜移植手术。比较两组 3 个月和 6 个月后内皮细胞密度(ECD)和内皮细胞丢失。
A 组(n=35)与 B 组(n=45)的 3 个月时 ECD 分别为 2228±270/mm2和 2302±254/mm2(P=0.48),6 个月时 ECD(n=23 和 22)分别为 2058±324/mm2和 2118±260/mm2(P=0.72)。相应的内皮细胞丢失率分别为 3 个月时的 23.3%±6.8%和 20.3%±6.1%(P=0.18)和 6 个月时的 29.1%±8.4%和 26.7%±8.0%(P=0.34)。A 组的前板层组织中,17 个(45.9%)用于深层前板层角膜移植,18 个(48.6%)用于更大的治疗性和修复性移植物,2 个用于角膜假体载体。两组供体脱离率(8.6%与 8.9%)相似,均无原发性移植物失败。
BCL 界面技术是一种用于标记 DMEK 移植物的简单、安全的技术。在供体短缺期间,前角膜组织可用于进行额外的角膜移植。